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Hepatic Ischemic Preconditioning Provides Protection Against 
Distant Renal Ischemia and Reperfusion Injury in Mice
We previously demonstrated that there are acute and delayed phases of renal protection 
against renal ischemia and reperfusion (IR) injury with renal ischemic preconditioning (IPC). 
This study assessed whether hepatic IPC could also reduce distant renal IR injury through 
the blood stream-mediated supply of reactive oxygen species (ROS). Male C57BL/6 mice 
were randomly divided into four groups: group I, sham operated including right 
nephrectomy; group II (IR), left renal ischemia for 30 min and reperfusion injury; group III 
(IPC-IR), hepatic ischemia for 10 min followed by 10 min of reperfusion before left renal IR 
injury; group IV (MPG - IPC + IR), pretreated with 100 mg/kg N-(2-mercaptopropionyl)-
glycine (MPG) 15 min before hepatic IPC and left renal IR injury. Renal function, 
histopathologic findings, proinflammatory cytokines, and cytoprotective proteins were 
evaluated 15 min or 24 hr after reperfusion. Hepatic IPC attenuated the expression of 
proinflammatory cytokines, tumor necrosis factor α, intercellular adhesion molecule 1, 
and induced inducible nitric-oxide synthase, and the phosphorylation of Akt in the murine 
kidney. Renal function was better preserved in mice with hepatic IPC (group III) than 
groups II or IV. Hepatic IPC protects against distant renal IR injury through the blood 
stream-delivery of hepatic IPC-induced ROS, by inducing cytoprotective proteins, and by 
inhibiting inflammatory reactions.
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INTRODUCTION
Renal ischemia and reperfusion (IR) injury is a major cause of 
acute kidney injury during the perioperative period, and occurs 
frequently after aortovascular surgery or kidney transplantation 
(1, 2). The pathophysiology of IR injury includes both direct cel-
lular damage as the result of the ischemic insult as well as de-
layed dysfunction and damage insulting from activation of in-
flammatory pathways (3). Tumor necrosis factor (TNF), adenos-
ine, nitric oxide (NO), heat shock proteins (HSP), insulin-like 
growth factor, and cell adhesion molecules have been implicated 
in mechanisms that limit IR-induced injury following ischemic 
preconditioning (IPC) (4). However, the signaling pathway acti-
vated by IPC that prevent IR-induced damage is incompletely 
characterized.
  Recent studies have shown that activation of the Akt pathway 
plays a protective role during IR (3, 5, 6). Also, we previously 
demonstrated acute and delayed phases of renal protection with 
renal IPC, and that acute IPC is mediated via G-protein (Gi/o) 
and Akt phosphorylation, whereas delayed IPC involves Gi/o 
and inducible nitric oxide synthase (iNOS) upregulation (7).
  This study was designed to investigate the hypothesis that re-
active oxygen species (ROS) may be released by hepatic IPC as 
a remote organ and carried to the target tissue in the blood stream, 
making them available to activate Akt (protein kinase B) signal-
ing pathways and reduce inflammatory reactions. The study of 
the effects of hepatic IPC on distant kidney may help clarify the 
protective mechanisms of IPC, which may lead to the identifi-
cation of new molecular targets for therapeutic interventions.
MATERIALS AND METHODS
Induction of hepatic IPC and renal IR injury
All experiments conformed to the guidelines of and were ap-
proved by the Institutional Laboratory Animal Care and the Eth-
ical Committee of the Catholic University of Korea, Seoul, Korea 
(#2011-0035) on 8 February 2011. All animals were housed in 
separate cages with a 12 hr light-dark cycle and sufficient water 
and food. Mice were allowed to acclimatize for 7 days before the 
experiments. All experiments on mice were performed during 
the period from March 1 to 31, 2011.
  Male C57BL/6 mice (25-30 g) were anesthetized with intra-
peritoneal pentobarbital, 50 mg/kg or to effect. Mice were placed 
under a heating lamp and on a 37°C heating pad. After a mid-Lee JA, et al.  •  Renal Protection by Hepatic Ischemic Preconditioning
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line laparotomy and intraperitoneal application of 20 U of hep-
arin, all mice had a right nephrectomy and dissection of the left 
renal and hepatic pedicle. The mice were divided into four groups. 
Group I (sham, n = 8) had a sham operation to assess the effect 
of laparotomy and dissection of the left renal and hepatic pedi-
cle after right nephrectomy. In group II (IR, n = 8), group III (IPC-
IR, n = 8) and group IV (MPG - IPC + IR, n = 8), renal IR injury 
was created by placing a microvascular clamp on the left renal 
pedicle for 30 min (1, 7). In group III, hepatic IPC was achieved 
by brief clamping of the hepatic pedicle for 10 min, followed by 
10 min of reperfusion (3), before renal IR injury. In group IV, 
mice were pretreated with 100 mg/kg N-(2-mercaptopropionyl)-
glycine (MPG; a free radical scavenger) 15 min before hepatic 
IPC and were subjected to renal IR injury (7).
  Twenty-four hours after renal IR injury, all mice were re-anes-
thetized and plasma samples and left kidneys were obtained. 
For studying the renal effect of hepatic IPC, mice (n = 16) were 
subjected only to hepatic IPC without renal IR injury, and the 
left kidney was isolated 15 min (acute, n = 8) or 24 hr (delayed, 
n = 8) later. The experiments with pretreated MPG mice (n = 16) 
were performed in the same way.
Immunoblot analyses for protective proteins
The harvested kidneys were quickly frozen using liquid nitrogen 
and stored at -80°C. They were dissected on ice and immediately 
placed on ice-cold radioimmunoprecipitation assay (RIPA) buf-
fer (150 mM NaCl, 50 mM Tris-HCl, 1 mM EDTA, and 1% Tri-
ton-X100 [pH 7.4]) and homogenized for 10 sec on ice. Tissues 
were centrifuged at 32,500 g and 4°C under a vacuum for 1 hr. 
The supernatant was collected and used for immunoblotting as 
described previously (1, 7). Samples were stabilized with Laem-
meli buffer after determining their protein amounts by Bradford 
assay (BioRad, Hercules, CA, USA) using bovine serum albu-
min as standard. The proteins, separated by 4 hr 10% sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis at 80 V, were 
transferred to polyvinylidene fluoride membranes. Membranes 
were washed with Tris-buffered saline containing 0.1% Tween- 
20 (TBST) and coated with a blocking solution (5% dry milk in 
TBST). Measurements of iNOS, phosphorylated Akt (p-Akt), and 
total Akt were made by immunoblotting. The primary antibod-
ies for p-Akt and total Akt were from Cell Signaling Technolo-
gies (Danvers, MA, USA). iNOS antibody was from BD Biosci-
ences Pharmingen (San Jose, CA, USA). The secondary antibody 
(goat anti-rabbit or anti-mouse IgG conjugated to horseradish 
peroxidase at 1:5,000 dilution) was detected with enhanced che-
miluminescence immunoblotting detection reagents (Amer-
sham, Piscataway, NJ, USA), with subsequent exposure to a CCD 
camera coupled to a UVP Bio-imaging system (UVP, Upland, 
CA, USA). The band intensities of the immunoblots were within 
the linear range of exposure for all experiments.
 
Semiquantitative reverse transcriptase polymerase chain 
reaction (RT-PCR) for mRNA of proinflammatory 
cytokines 
Semi-quantitative RT-PCR was carried out to analyze the expres-
sion of the proinflammatory cytokines (TNF-α) and intercellu-
lar adhesion molecule 1 (ICAM-1) (8, 9). A 1 mL aliquot of Trizol 
reagent (MRC, Cincinnati, OH, USA) was added to the harvest-
ed kidneys, which were homogenized and allowed to stand for 
5 min. After adding 0.2 mL 1-bromo-3-chloropropane (Sigma-
Aldrich, St. Louis, MO, USA), centrifugation was carried out for 
15 min at 14,000 g. Subsequently, after separating supernatants 
and adding an equal amount of phenol: chloroform (5:1; pH 4.7) 
(Sigma-Aldrich), centrifugation was carried out for 10 min at 
14,000 g. After separating supernatants, adding 100% ethanol 
and allowing the solution react for 1 hr at -20°C, centrifugation 
was carried out for 10 min at 14,000 g. The solution was kept in 
at -70°C after discarding supernatants, washing RNA deposits 
with 75% ethanol, adding diethylene-pyrocarbonate water, and 
allowing the solution to react for 5 min at 60°C. RNA concentra-
tions were determined by spectrophotometric absorbance at 
260 nm. With extracted RNA (0.5 μg) as the template, cDNA       
(50 μL) was composed using avian myeloblastosis virus (AMV) 
reverse transcriptase (Promega, Madison, WI, USA). PCR was 
done after generating the last reaction liquid 10 μL, including 
dNTPs (each at 2.5 mM/L), 1 unit I Start Taq DNA polymerase 
(Intron, Seoul, Korea), and each primer of 20 μM using com-
posed cDNA of 2 μL (Table 1). PCR was done for 35 cycles through 
30 sec denaturation at 95°C, 30 sec annealing at 55°C, and 1 min 
extension at 72°C, and completed after reacting for 10 min at 
72°C. β-actin (228 bp) was the internal control gene to determine 
whether appropriate mRNA had been separated from cells.   
Table 1. Reverse transcriptase-PCR primer sequences
Primer   Accession number                       Sequence (5´→ 3´) Size (bp) Cycle number
Annealing temperature 
(°C)
β-actin NM031144 F: AGCCATGTACGTAGCCATCC
R: CTCTCAGCTGTGGTGGTGAA
228 35 55
TNFα X66539
S40199
F: TACTGAACTTCGGGGTGATCGGTCC
R: CAGCCTTGTCCCTTGAAGAGAACC
295 35 62
ICAM1 S46779 F: TTTCGATCTTCCGACTAGGG
R: AGCTTCAGAGGCAGGAAACA
113 35 55
TNFα, tumor necrosis factor α; ICAM1, intercellular adhesion molecule 1.Lee JA, et al.  •  Renal Protection by Hepatic Ischemic Preconditioning
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Extended PCR products were quantified using Gel DocTM XR 
(BioRad) after 2.0% agarose gel electrophoresis and staining 
with ethidium bromide dye.
Measurement of serum creatinine level
Renal function was assessed by measurement of serum creati-
nine 24 hr after renal IR injury. Serum creatinine levels were mea-
sured spectrophotometrically using a commercially available 
quantitative colorimetric assay (Sigma-Aldrich) (10). 
Histological examinations 
The harvested kidneys were fixed in 10% formalin solution, em-
bedded in paraffin, sectioned at 5 μm thickness, and stained with 
hematoxylin-eosin. Morphological assessment was performed 
by an experienced renal pathologist who was unaware of the 
treatment that the animal had received. A previously described 
grading scale of 0-4 (11) was used for the histopathological as-
sessment of ischemia and reperfusion-induced damage of the 
proximal tubules. 
 
Statistical analyses
Data are mean ± SEM. Statistical processing was done using 
SPSS 12.0 (SPSS, Chicago, IL, USA). Data were analyzed using       
t test or the analysis of variance (ANOVA). The ordinal values of 
the Jablonski scale were analyzed by the Kruskal-Wallis non-
parametric test with Dunnett’s test comparison among groups. 
A P value of  < 0.05 was considered statistically significant.
 
RESULTS
Immunoblotting for iNOS, p-Akt, and Akt
Kidneys collected 15 min after hepatic IPC displayed elevation 
of p-Akt by 85% without affecting iNOS or Akt expression (P =  
0.011) (Fig. 1). Kidneys collected 24 hr after hepatic IPC displayed 
a significant elevation (44%) in the expression of iNOS (P =  
0.038), but elevated expressions of p-Akt at the acute phase were 
abolished. On the other hand, elevations of protective proteins 
caused by hepatic IPC did not appear in acute and delayed phase 
of pretreated MPG mice (Fig. 1).
RT-PCR of proinflammatory genes
Kidney inflammation was determined by the measurement of 
mRNA-encoding markers of inflammation, including TNF-α 
and ICAM-1 at 24 hr after renal IR injury. Although there were 
significant elevations in TNF-α and ICAM-1 level in group II 
(66.7 ± 8.7 and 91.9 ± 13.7; P < 0.001, respectively) vs group I 
(44.6 ± 7.5 and 61.7 ± 8.9, respectively), these elevations were 
markedly attenuated in group III (52.4 ± 7.4 and 67.3 ± 10.1, re-
spectively; P = 0.003 and P = 0.001) vs group II (Fig. 2). Proin-
flammatory genes were significantly re-elevated in MPG pre-
treated group IV (62.6 ± 8.3 and 89.7 ± 12.8, respectively; P =  
0.022 and P = 0.002) vs group III (Fig. 2). 
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Fig. 1. Changes of inducible nitric oxide synthase (iNOS), phosphorylated Akt (pAkt) and 
total Akt from left renal cortices of mice subjected to sham operation (n = 8), 15 min 
(n = 8) or 24 hr (n = 8) after hepatic IPC, and 15 min (n = 8) or 24 hr (n = 8) after 
pretreated N-(2-mercaptopropionyl)-glycine (MPG) and hepatic IPC. (A) Representa-
tive immunoblots. (B) Densitometric quantifications of relative band intensities. *P < 
0.05 vs sham, 
†P < 0.05 vs IPC operated. Error bars = 1 SEM.
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Fig. 2. Changes of proinflammatory cytokine, TNFα and ICAM1 from left renal corti-
ces of mice subjected to sham operation (n = 8), renal IR group (n = 8), hepatic IPC 
+ IR group (n = 8) and MPG-hepatic IPC + IR group (n = 8). (A) Representative RT-
PCR images. (B) Densitometric quantifications of band intensities. *P < 0.05 vs sham 
group, 
†P < 0.05 vs IR group, 
‡P < 0.05 vs IPC + IR group. TNFα, tumor necrosis 
factor α; ICAM1, intercellular adhesion molecule 1; IPC, ischemic preconditioning; IR, 
ischemia and reperfusion injury; MPG, N-(2-mercaptopropionyl)-glycine.Lee JA, et al.  •  Renal Protection by Hepatic Ischemic Preconditioning
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Protective effects against renal IR injury of hepatic IPC
As expected, serum creatinine at 24 hr after reperfusion was sig-
nificantly elevated in group II (IR, 2.7 ± 0.6 mg/dL; n = 8; P <  
0.001) and group IV (MPG - IPC + IR, 2.2 ± 0.5 mg/dL; n = 8; P <  
0.001) compared with group I (sham operation, 0.4 ± 0.1 mg/dL; 
n = 8) (Fig. 3). Hepatic IPC in group III (IPC + IR, 0.6 ± 0.1 mg/dL; 
n = 8; P < 0.001) significantly improved renal function compared 
with group II. However, renal protective effects of hepatic IPC 
were lost by MPG treatment in group IV (P < 0.001) vs group III 
(Fig. 3).
  Histopathologic findings at 24 hr after reperfusion were near-
ly normal in hepatic IPC treated animals (group III) (Fig. 4). In 
contrast, several areas of tubular dilation and necrosis, medul-
lary luminal congestion, and hemorrhage were present in the 
kidneys of mice subjected to IR (group II) and pretreated MPG 
before hepatic IPC and renal IR (group IV) (Fig. 4). Jablonski his-
tology grading scores in the outer medullary of kidneys are 
shown in Fig. 5. Groups II and IV resulted in severe acute tubular 
necrosis (grade 3.5 ± 0.5 and 3.3 ± 0.5, respectively; P < 0.001) vs 
sham grade (0.2 ± 0.3). Group III (grade 1.1 ± 0.6; P < 0.001) 
showed significantly improved necrosis scores compared with 
groups II and IV.
A B
C D
Fig. 4. Representative HE stained photomicrographs of the kidney (magnification, × 200). (A) Outer medulla of a sham-operated mouse. (B) Mouse subjected to IR. (C) Mouse 
with hepatic IPC + IR. (D) Mouse with MPG-hepatic IPC + IR. IPC, ischemic preconditioning; IR, ischemia and reperfusion injury; MPG, N-(2-mercaptopropionyl)-glycine. 
Fig. 3. Plasma creatinine levels in mice subjected to sham operation (n = 8), renal IR 
group (n = 8), hepatic IPC + IR group (n = 8) and MPG-hepatic IPC + IR group (n = 8). 
*P < 0.001 vs sham group, 
†P < 0.001 vs IR group, 
‡P < 0.001 vs IPC + IR group. 
IPC, ischemic preconditioning; IR, ischemia and reperfusion injury; MPG, N-(2-merca- 
ptopropionyl)-glycine.
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DISCUSSION
Acute kidney injury frequently results from renal IR injury and 
is a major contributor to morbidity and mortality during the peri-
operative period. Ischemic preconditioning is a phenomenon 
whereby brief periods of ischemia protect the organ against a 
more sustained ischemic insult. Previous studies in animal mod-
els demonstrated that renal or hepatic ischemic precondition-
ing protects against more prolonged IR injury (3, 6, 7). IPC also 
has protective effects on distant IR injured organs (12-14). But, 
only a few studies have been conducted to ascertain the effect 
of IPC on a remote organ; the results were equivocal and the 
mechanism of IPC was unclear. Therefore, the present study was 
undertaken to determine whether hepatic IPC could protect 
against renal IR injury, and to further elucidate the role of ROS 
induced by hepatic IPC in attenuating this injury. 
  Many endogenous neurotransmitters, peptides, and hor-
mones have been proposed to function in the signal transduc-
tion pathways that mediate the cytoprotective effect of IPC. IPC 
shares many fundamental steps, including activation of G-pro-
tein coupled receptors, multiple protein kinases and ATP-sensi-
tive potassium channels (15). Experimental studies have shown 
that the protective effects of hepatic IPC are triggered by the re-
lease of adenosine and NO and the subsequent activation of sig-
nal networks involving protein kinases such as phosphatidylino-
sitol 3-kinase (PI3K), protein kinase C, and p38 mitogen-acti-
vated protein kinases (MAPK), and transcription factors such 
as signal transducer and activator of transcription 3, nuclear 
factor-κB and hypoxia-inducible factor 1 (16). NO modulates 
mitochondrial function, mediates cytoprotection after IR, and 
has been implicated in the signaling of the highly protective IPC 
program (17, 18). In cardiac and neuronal IR injury, acutely pro-
tective effects of IPC dissipate over several hours but reappear 
24-72 hr later. This phenomenon is defined as a second window 
of protection, or delayed IPC, and is proposed to be mediated by 
iNOS upregulation and enhanced release of NO in these organs 
(7, 19). In this study, we observed approximately 40% upregula-
tion of iNOS in the kidneys of mice 24 hr after hepatic IPC. Inhi-
bition of ROS function with MPG prevented the elevation of iNOS 
24 hr after hepatic IPC. Finally, induction of iNOS was critical 
for the mechanism of delayed renal protection. 
  The PI3K kinase/Akt pathway is an important survival path-
way in protection against IR injury. Activation of this pathway 
promotes cell survival in part by its modulation of various down-
stream elements involved in apoptosis. Recent studies have 
shown that activation of the Akt pathway plays a protective role 
during IR injury (5, 6). Phosphorylation of Akt caused by IPC 
begins as early as 15 min after reperfusion (3). Presently, p-Akt 
also increased by approximately 80% in only 15 min after hepatic 
IPC, and remained elevated for 24 hr. However, the level of total 
Akt expression did not significantly change after reperfusion. 
The major effect in the acute stage after hepatic IPC was an im-
mediate increase in Akt phosphorylation of distant kidney fol-
lowing reperfusion.
  Previous animal studies demonstrated that, although high 
concentrations of oxygen free radicals induce tissue injury dur-
ing the reperfusion period after prolonged ischemia, moderate 
oxygen free radicals are an important prerequisite of IPC in car-
diac, hepatic, and renal cells (7, 20, 21). Oxygen free radicals 
phosphorylate several important cytoprotective kinases, includ-
ing extracellular signal-regulated kinase (ERK1/2), MAPK and Akt, 
and are involved in the upregulation of several cytoprotective 
genes (22). ROS are attractive signaling candidates to account 
for preconditioning in the kidney because renal cells are subject 
to obligatory bursts of oxidant stress during the reperfusion phase 
after each preconditioning stimulus. Therefore, distant renal 
exposure through the blood stream of moderate ROS caused by 
hepatic IPC may also initiate cytoprotective signaling to defend 
against subsequent and more severe free radical-mediated in-
jury in renal tubule cells. The present observation that the free 
radical scavenger MPG prevented the remote renal protective 
effects by hepatic IPC supports this scenario.
  Activation of the Akt signaling pathway and increased NO sup-
press inflammatory reactions, which are important contributors 
to renal IR injury (6, 23, 24). NO also regulates neutrophil recruit-
ment by inhibiting the expression of adhesion molecules in the 
vascular endothelium, resulting in increased blood flow to isch-
emic regions (25). Therefore, reduction of the inflammatory re-
sponse by hepatic IPC can produce beneficial effects in renal IR 
injury. The present study demonstrates that the levels of the pro-
inflammatory cytokines TNF-α and ICAM-1 24 hr after renal IR 
injury were lower in mice treated with hepatic IPC (group III) than 
in mice not similarly-treated (group II) and in MPG-pretreated 
Fig. 5. Jablonski grading scale scores of outer medullary area for the histologic ap-
pearance of acute tubular necrosis in sham-operated mice (n = 8), mice subjected IR 
(n = 8), hepatic IPC + IR group (n = 8) and MPG-hepatic IPC + IR group (n = 8). *P < 
0.001 vs sham group, 
†P < 0.001 vs IR group, 
‡P < 0.001 vs IPC + IR group. IPC, 
ischemic preconditioning; IR, ischemia and reperfusion injury; MPG, N-(2-mercap- 
topropionyl)-glycine.
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mice (group IV). Attenuation of the expression of these cytokines 
from distant kidneys by hepatic IPC may contribute to the reduc-
tion in renal inflammatory injury after IR. The lesser injury on 
histopathologic and biochemical studies in kidneys of hepatic 
IPC pretreated mice was predictive of better renal function.
  In conclusion, hepatic IPC directly reduces necrosis and in-
flammation in distant kidneys via mechanisms involving reduc-
tion in proinflammatory mRNAs. Hepatic IPC also induces phos-
phorylation of Akt and upregulation of iNOS in the kidney through 
the blood stream of hepatic-released ROS. Clinical manipula-
tion of the signaling pathways of remote IPC that mediate pro-
tection may lead to therapeutic improvements to prevent or re-
duce the incidence of acute kidney injury during the periopera-
tive period. 
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